Latest Developments in Global Blood Collection Devices Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Blood Collection Devices Market

  • Healthcare
  • May 2024
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

  • In April 2024, Streck introduced Protein Plus BCT, a new direct draw whole blood collection tube designed to stabilize plasma protein concentrations during storage at room temperature. This launch expands the company's product portfolio and strengthens its competitive position in the market
  • In April 2024, Becton, Dickinson and Company (BD) introduced the BD Vacutainer UltraTouch Push Button Blood Collection Set in India. This innovative product features BD RightGauge technology, allowing the use of a thinner needle for blood collection, and BD PentaPoint technology to significantly reduce insertion pain for patients
  • In January 2025, Fresenius Kabi announced that the FDA granted 510(k) clearance for its Adaptive Nomogram, an alternative algorithm for the Aurora Xi Plasmapheresis System, aimed at optimizing plasma collection efficiency
  • In March 2025, BD (Becton, Dickinson and Company) and Babson Diagnostics announced results of new studies demonstrating that common blood tests using several drops of blood collected via the BD MiniDraw Capillary Blood Collection System are as accurate as higher-volume draws from veins, potentially improving patient access to testing
  • In October 2024, Terumo Blood and Cell Technologies kicked off the U.S. launch of the Reveos Automated Blood Processing System with Blood Centers of America. Used globally for over a decade, Reveos targets efficiency and bolstering the platelet supply
  • In November 2023, BD introduced the PIVO Pro Needle-free Blood Collection Device, which allows blood samples to be drawn directly from a patient's peripheral IV line without using a traditional needle. This device builds upon BD's existing PIVO technology
  • In January 2023, Capitainer collaborated with AstraZeneca to use a novel device from Capitainer to develop protocols for biomarkers relevant to AstraZeneca's clinical drug programs